Chattem, Inc. (NASDAQ:CHTT)

CAPS Rating: 5 out of 5

Marketer and manufacturer of a broad portfolio of branded over-the-counter healthcare products, toiletries and dietary supplements including such categories as topical analgesics, medicated skin care products, medicated dandruff shampoos and conditioners.

Recs

1
Player Avatar MNNice (< 20) Submitted: 2/8/2009 10:03:23 AM : Underperform Start Price: $69.00 CHTT Score: +19.10

CHTT is being sued by Lectec corp for patent infringement of Lectec's transdermal patch technology. On Friday, Feb 6th, Lectec filed a preliminary injunction against the defendants. The motion is very strong. Lectec has two re-examined patents...no re-examined patent has ever been found invalid in a court of law. A top legal firm, Radar, and the case is being tried in Texarcana, the rocket-docket that's also very plaintiff friendly in patent infringement lawsuits. Lectec has an expert witness, Dr. Guy. Many other witnesses and documents will come to light.

Featured Broker Partners


Advertisement